Aclaris Therapeutics to Attend Upcoming Investor Conferences

MALVERN, Pa., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage specialty pharmaceutical company, today announced that management will host investor meetings during:

• Citi’s 2016 Global Healthcare Conference in New York, NY on Thursday, December 8, 2016
• Guggenheim’s 2016 Annual Healthcare Conference in Boston, MA on Tuesday, December 13, 2016

About Aclaris Therapeutics, Inc.Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology.  Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting Aclaris’ website at www.aclaristx.com.

Contact:

Aclaris Contact
Michael Tung, M.D.
Vice President / Investor Relations
484-329-2140
[email protected]

Media Contact
Mariann Caprino
TogoRun
917-242-1087
[email protected]

You May Also Be Interested In

• Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
• NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C.
• What If Your Selfie Became a Game? DREAMOSIS Turns You and Anything You Own Into a Collectible World